Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03931551 |
| Title | Olaparib+Trastuzumab in HER2[+],Breast Cancer Susceptibility Gene (BRCA) Mutated Advanced Breast Cancer (OPHELIA) |
| Acronym | OPHELIA |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | MedSIR |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | ESP |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Hospital Universitari Vall d'Hebron | Barcelona | 08035 | Spain | Details | ||
| Complejo Hospitalario de Jaén | Jaén | 23007 | Spain | Details | ||
| Hospital Clínico San Carlos | Madrid | 28040 | Spain | Details | ||
| Hospital Virgen del Rocío | Sevilla | 41013 | Spain | Details |